Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18101594 | 0.92 | ALOX5 (0.30) | — | |
| SCHEMBL18101577 | 0.91 | ALOX5 (0.30) | MEN1KMT2A | |
| SCHEMBL18101600 | 0.90 | ALOX5 (0.33) | KDM4EMEN1ALDH1A1HPGDKMT2A | |
| SCHEMBL18101596 | 0.90 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL18101580 | 0.90 | ALDH1A1 (0.32) | KDM4EALDH1A1MAPT | |
| SCHEMBL18101581 | 0.89 | ALOX5 (0.32) | ALDH1A1MAPT | |
| SCHEMBL18101579 | 0.89 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL18101610 | 0.89 | MAPT (0.32) | MEN1MAPTKMT2A | |
| SCHEMBL18101706 | 0.89 | — | — | |
| SCHEMBL18101598 | 0.89 | KDM4E (0.33) | KDM4EMEN1NPC1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3196198-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | Idemitsu Kosan Co., Ltd (JP) | 2017-07-26 | — | — | EP | disclosed |
| US-20160284998-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20160284998-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160284998-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME | EPB41, RPS4X, OR10J3 | KDM4E 1375/4885MEN1 1397/4885NPC1 3399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.